AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25090173
Drug: Linkage group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linkage group (buprenorphine induction, intrahospital dose stabilization, and postdischarge transition to maintenance buprenorphine OAT)
Trial: 22997755
Drug: Citoflavin included
RxNorm normalized name: Riboflavin
DrugBank: Riboflavin (DB00140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citoflavin included in the complex program of intensive therapy
Trial: 10445787
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 250 mg + Metronidazole (MET) 3 x 125 mg/day
Trial: 11251357
Drug: Prolonged prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged prophylaxis with low-molecular-weight heparin (LMWH)
Trial: 11251357
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of administering LMWH (including teaching self-administration and follow-up visit)
Trial: 10534208
Drug: Trovafloxacin 200
RxNorm normalized name: trovafloxacin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 200 mg once daily for 5 days
Trial: 23322466
Drug: Tocilizumab-MTX 8
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tocilizumab-MTX 8 mg/kg
Trial: 8944373
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg daily (OME40)
Trial: 2936636
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2% miconazole nitrate and 5% benzoyl peroxide applied twice daily
Trial: 25824852
Drug: Community treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community treatment by experts (CTBE)
Trial: 19467175
Drug: Mometasone furoate,
RxNorm normalized name: Mometasone Furoate, 50 mcg/inh nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mometasone furoate, 200 mcg once daily
Trial: 28403910
Drug: Jaungo and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jaungo and placebo ointment applied once a day for 3 weeks
Trial: 15297081
Drug: Synbiotic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic preparation (Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus with oligofructose)
Trial: 11979067
Drug: Single-dose nicotine
RxNorm normalized name: nicotine Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose nicotine
Trial: 21208922
Drug: No varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No varicella vaccine
Trial: 389264
Drug: Ibuprofen administration
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen administration
Trial: 3355619
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of encapsulated fish oil per day
Trial: 3355619
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of encapsulated safflower oil (placebo) per day
Trial: 2776141
Drug: Flosequinan 100
RxNorm normalized name: flosequinan 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan 100 mg orally once daily for 3 days
Trial: 10587284
Drug: Haloperidol 25
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol 25 mg/day + Lithium
Trial: 3924286
Drug: Honey in
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey in oral rehydration solution
Trial: 9020945
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus methylprednisolone (250 mg IV)
Trial: 18290565
Drug: Calcineurin inhibitors
RxNorm normalized name: Calcineurin inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcineurin inhibitors and steroids only (Control)
Trial: 23374677
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 5 mg
Trial: 7134228
Drug: Fluid monovalent
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid monovalent influenza A/New Jersey/8/76 vaccines (double the antigen content)
Trial: 30151994
Drug: V- AS
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: V- AS group (vonoprazan 20-mg bid, amoxicillin 750-mg bid, sitafloxacin 100-mg bid for 7 days)
Trial: 8559949
Drug: Stopped light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopped light treatment early during winter (n = 6)
Trial: 2706319
Drug: Marketing Suspension
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketing Suspension (MS)
Trial: 7980076
Drug: nifedipine retard
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nifedipine retard 20 mg
Trial: 1827042
Drug: cilazapril 2.5
RxNorm normalized name: cilazapril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilazapril 2.5 mg
Trial: 9140802
Drug: Nebivolol 5
RxNorm normalized name: nebivolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol 5 mg once daily
Trial: 7833497
Drug: Insulin at
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin at 50 microU/mL
Trial: 17537539
Drug: SPLENDA Sucralose
RxNorm normalized name: Sucralose
DrugBank: Sucralose (DB15049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPLENDA Sucralose control (250 ml with water)
Trial: 11709454
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment from general practitioner including patient education and drug treatment if necessary)
Trial: 366722
Drug: benoxaprofen 200
RxNorm normalized name: fenoprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benoxaprofen 200 mg b.d. for three weeks
Trial: 25210836
Drug: Biannual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biannual mass azithromycin treatment (6 distributions)
Trial: 22010915
Drug: Earlier-ART group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Earlier-ART group (ART initiated within 4 weeks after the start of tuberculosis treatment, 214 patients)
Trial: 7615781
Drug: Inhaled beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta 2 agonist alone
Trial: 19755670
Drug: Sodium salicylate
RxNorm normalized name: Sodium Salicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium salicylate (4.5 g/day)
Trial: 19755670
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium salicylate (SS)
Trial: 30901440
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplement (treatment group)
Trial: 26577754
Drug: Etonogestrel (ENG)
RxNorm normalized name: Etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etonogestrel (ENG) implant
Trial: 17967219
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% (10 mg)
Trial: 21785860
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sildenafil
Trial: 11564390
Drug: Omapatrilat 25
RxNorm normalized name: OMAPATRILAT
DrugBank: Omapatrilat (DB00886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat 25 mg
Trial: 30946283
Drug: Laparoscopic pelvic
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic pelvic organ prolapse suspension operation
Trial: 11795452
Drug: Microwave treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microwave treatment
Trial: 11119198
Drug: Rectal diclofenac
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal diclofenac 2 mg.kg(‐1) following oral placebo premedication
Trial: 11119198
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine premedication
Trial: 29858418
Drug: Verum acupuncture
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum acupuncture and placebo medicine
Trial: 19917888
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg daily
Trial: 11288822
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with nitrendipine
Trial: 17485422
Drug: Tocilizumab monotherapy
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab monotherapy at 8 mg/kg intravenously every 4 weeks
Trial: 14745142
Drug: Intravenous nicorandil
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicorandil
Trial: 9433338
Drug: Fixed haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fixed haloperidol doses intended to achieve plasma levels of 8‐18 ng/ml
Trial: 15452834
Drug: Cisplatin plus
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin plus paclitaxel (two dose levels)
Trial: 15179409
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g powder without hyperforin, tea, juice, oil extract, hyperforin-free extract (Ze 117), low daily doses of hyperforin-containing Hypericum powder (1 g, 0.5 g)
Trial: 7019641
Drug: Terbutaline sulphate
RxNorm normalized name: Terbutaline sulphate
DrugBank: Terbutaline (DB00871)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terbutaline sulphate 0.5 mg via metered aerosol
Trial: 7019641
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered theophylline 5 mg/kg
Trial: 2038732
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of terbutaline and theophylline
Trial: 3328284
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg x 2 for 4-8 weeks (up to 12 weeks for gastric ulcers)
Trial: 27917729
Drug: Topical triamcinolone
RxNorm normalized name: triamcinolone Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical triamcinolone
Trial: 15484727
Drug: Pea meal
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pea meal diet (200 g/kg)
Trial: 2661658
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg two times daily
Trial: 27917729
Drug: Oral dapsone
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dapsone
Trial: 18940558
Drug: Botulinum injection
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum injection followed by physiotherapy
Trial: 12689686
Drug: Ibandronate 2.5
RxNorm normalized name: ibandronate 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 2.5 mg taken 60 minutes before breakfast
Trial: 1954661
Drug: American ginseng
RxNorm normalized name: American ginseng
DrugBank: Panax quinquefolius whole (DB14296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: American ginseng compound liquor (treated group)
Trial: 21219551
Drug: Artesunate and
RxNorm normalized name: artesunate and mefloquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artesunate and Mefloquine (fixed dose combination)
Trial: 9137798
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 480 mg/day
Trial: 2493302
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa 5 megaunits (MU) daily for one week, reducing to 5 MU thrice weekly for seven weeks, then 3 MU thrice weekly for eight weeks
Trial: 16834525
Drug: Drug laboratory
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug laboratory monitoring alerts within the CPOE system
Trial: 2442610
Drug: Saline (placebo)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (placebo) 0.5 ml/kg body weight, administered intramuscularly at 2, 6, and 10 months of age.
Trial: 16824993
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine (LDD) infusion (7.5 microg/kg/min)
Trial: 10708231
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (timolol maleate, carteolol, metipranolol)
Trial: 30139340
Drug: Postoperative intravenous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative intravenous infusion of somatostatin for 6 days
Trial: 31100514
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion for 6 days
Trial: 27725233
Drug: Hyaluronic Acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic Acid (HA) injection (10 cc)
Trial: 2856773
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg once daily
Trial: 10322831
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of Xuefu Zhuyu decoction and move stripe field radiation
Trial: 12665756
Drug: Peppermint oil
RxNorm normalized name: Peppermint Oil
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peppermint oil solution administered intraluminally
Trial: 30852486
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Traditional Chinese medicine Zhiyi decoction)
Trial: 3403422
Drug: Hot air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hot air inhalation (ambient air)
Trial: 30400937
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (LDA) 100 mg/d, prescribed at night, starting from early pregnancy (12-20 weeks of gestation) until 34 weeks of gestation.
Trial: 27443451
Drug: Twice-daily treatment
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily treatment of valaciclovir
Trial: 24355050
Drug: β-carotene from
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-carotene from dietary supplements
Trial: 24355050
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C from dietary supplements
Trial: 24355050
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E from dietary supplements
Trial: 24516261
Drug: Alternate day
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate day therapy with atorvastatin 10 mg and fenofibrate 160 mg
Trial: 22545737
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for adherence and depression (CBT-AD)
Trial: 24245566
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus renal-artery stenting
Trial: 22722513
Drug: Conventional switch
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional switch strategy (4 further weeks on escitalopram 10 to 20 mg/d, then switch to duloxetine if nonresponse)
Trial: 9260074
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine HCl (100 mg)
Trial: 21310305
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of mixed fibers
Trial: 12452319
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (Ang II) infusion at a constant dose of 50 ng/min
Trial: 29482026
Drug: Reduced fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced fluid output, weight loss, and diuretic efficiency (DE)
Trial: 12452319
Drug: Noradrenaline (NA)
RxNorm normalized name: noradrenaline hydrochloride
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Noradrenaline (NA) infusion with increasing doses (2‐256 ng/min)
Trial: 3049846
Drug: Nifedipine 80
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine 80 mg/day
Trial: 17364311
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (40 mg)
Trial: 27863271
Drug: Combined hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormonal oral pill
Trial: 2007359
Drug: Misoprostol 200
RxNorm normalized name: MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 200 micrograms four times daily
Trial: 6535339
Drug: Discontinue medication
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinue medication with no dietary intervention
Trial: 6535339
Drug: Discontinue medication
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinue medication and reduce weight
Trial: 6535339
Drug: Discontinue medication
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinue medication and reduce sodium
Trial: 29974637
Drug: Vehicle administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vehicle administration
Trial: 20509823
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g fibre (fructose-oligosaccharides) diet supplementation
Trial: 18417246
Drug: Platinum-based combination
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum-based combination chemotherapy (3 chemotherapy courses)
Trial: 30407932
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of rTMS treatment based on cBEI
Trial: 12065457
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 1000 mg, four injections every 6 weeks plus daily oral levonorgestrel (LNG, 250 microg)
Trial: 6271000
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g citrus pectin added to a mixed low fiber diet
Trial: 12095064
Drug: Tazarotene 0.1%
RxNorm normalized name: TAZAROTENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tazarotene 0.1% gel
Trial: 16519625
Drug: Vitamin K1
RxNorm normalized name: vitamin K1
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K1 10 mg per day injection intramuscularly or intravenously for 2‐7 days (n = 40)